Antineoplastic and immunosuppressive medicaments
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: > Other: > Other > Other: > Antineoplastic and immunosuppressive medicaments
Duty Rate (from China)
Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Products classified under HTS 3004.90.92.16
Tacrolimus 1mg Capsules
Tacrolimus capsules are immunosuppressive medicaments used to prevent organ transplant rejection, containing 1mg of the active ingredient in hard gelatin capsules for oral measured doses. Classified under HTS 3004.90.92.16 for retail-packed immunosuppressive products.
Mycophenolate Mofetil 500mg Tablets
Mycophenolate mofetil is an immunosuppressive prodrug inhibiting lymphocyte proliferation, used post-transplant in 500mg enteric-coated tablets. Under HTS 3004.90.92.16 for retail-packaged measured medicaments.
Pembrolizumab 100mg/4ml Solution
Pembrolizumab injection is an anti-PD-1 antineoplastic monoclonal antibody for various cancers, in 100mg/4ml vials for IV infusion. HTS 3004.90.92.16 applies to these dosed immunosuppressive therapies.
Imatinib Mesylate 400mg Tablets
Imatinib mesylate tablets are an antineoplastic medicament used primarily for treating chronic myeloid leukemia by inhibiting tyrosine kinase activity. They are put up in measured doses of 400mg per tablet in retail packaging, qualifying under HTS 3004.90.92.16 as an unmixed antineoplastic product for therapeutic use.
Cyclophosphamide 50mg Injection Vials
Cyclophosphamide is an immunosuppressive and antineoplastic agent used in chemotherapy for cancers and autoimmune diseases, supplied in sterile 50mg vials for measured dosing. It fits HTS 3004.90.92.16 as a put-up unmixed product for therapeutic retail sale or hospital use.
Rituximab 100mg/10ml Intravenous Infusion
Rituximab is a monoclonal antibody antineoplastic used for non-Hodgkin lymphoma and rheumatoid arthritis, provided in 100mg/10ml single-use vials for measured IV administration. It qualifies under HTS 3004.90.92.16 as an immunosuppressive biologic in dosed form.
Methotrexate 2.5mg Tablets
Methotrexate tablets are antineoplastic and immunosuppressive drugs used for cancer, psoriasis, and rheumatoid arthritis in low-dose 2.5mg scored tablets for precise therapeutic dosing. Falls under HTS 3004.90.92.16 for measured retail medicaments.
Everolimus 10mg Tablets
Everolimus is an mTOR inhibitor used as an antineoplastic for renal cell carcinoma and immunosuppressive for transplant rejection, in 10mg film-coated tablets. Classified in HTS 3004.90.92.16 for dosed immunosuppressive medicaments.
Azathioprine 50mg Tablets
Azathioprine tablets are purine analogs used as immunosuppressants for organ transplants and autoimmune conditions, in 50mg scored tablets for measured oral doses. HTS 3004.90.92.16 covers these put-up antineoplastic/immunosuppressive products.
Nivolumab 100mg/10ml Injection
Nivolumab is a PD-1 inhibitor monoclonal antibody antineoplastic for melanoma and lung cancer, supplied in 100mg/10ml preservative-free vials. It meets HTS 3004.90.92.16 criteria for measured-dose immunosuppressive biologics.